DVAX
Dynavax Technologies
Stock NASDAQ – Stock Market Prices, News & Analysis
Dynavax Technologies est centrée sur le développement de vaccins adjuvants pour renforcer la réponse immunitaire contre diverses maladies.
Dynavax Technologies
DVAX
Dynavax Technologies est centrée sur le développement de vaccins adjuvants pour renforcer la réponse immunitaire contre diverses maladies.
Price history of Dynavax Technologies
Price history of Dynavax Technologies
Performance & Momentum
Sanofi to acquire Dynavax for $2.2 billion
Sanofi has agreed to acquire Dynavax Technologies Corp, a company specializing in vaccines, including a marketed hepatitis B vaccine for adults and a phase 1/2 shingles vaccine candidate. This acquisition aims to strengthen Sanofi's adult immunization portfolio by combining Dynavax’s innovations with Sanofi’s global reach and development capabilities. Shares surged 40% following the announcement.
Similar stocks to Dynavax Technologies
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
